Literature DB >> 3475038

Comparative efficacy of broad-spectrum antiviral agents as inhibitors of African swine fever virus replication in vitro.

C Gil-Fernández, E De Clercq.   

Abstract

Various nucleoside analogues, selected on the basis of their previously established broad-spectrum antiviral properties, were evaluated for their potency and selectivity as inhibitors of the in vitro replication of the iridovirus, African swine fever virus (ASFV). The test compounds included (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine [(S)-HPMPA], 9-(2-phosphonylmethoxyethyl)adenine, (RS)-3-adenin-9-yl-2-hydroxypropanoic acid isobutyl ester, (S)-9-(2,3-dihydroxypropyl)adenine, carbocyclic 3-deazaadenosine (C-c3Ado), 3'-azido-2',3'-dideoxythymidine, pyrazofurin and ribavirin. As the most efficacious inhibitors of ASFV replication emerged (S)-HPMPA followed by C-c3Ado. The minimum inhibitory concentration of (S)-HPMPA for ASFV replication was 0.01 microgram/ml, and its selectivity index was 15,000. The corresponding values for C-c3Ado were 0.025 micrograms/ml and 8000, respectively. It would seem justified to further pursue these compounds for their anti ASFV activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3475038     DOI: 10.1016/0166-3542(87)90003-9

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  4 in total

1.  Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.

Authors:  E De Clercq; A Holý; I Rosenberg
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

2.  Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents.

Authors:  R Pauwels; J Balzarini; D Schols; M Baba; J Desmyter; I Rosenberg; A Holy; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

3.  Inhibition of African swine fever virus in cultured swine monocytes by phosphonoacetic acid (PAA) and by phosphonoformic acid (PFA).

Authors:  F Villinger; E V Genovesi; D J Gerstner; T C Whyard; R C Knudsen
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 4.  Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  H D Langtry; D M Campoli-Richards
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.